methylphenidate has been researched along with Inadequate Sleep in 13 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of a girl with Attention deficit hyperactivity disorder (ADHD) and Oppositional defiant disorder (ODD) who experienced a 3-hour episode of nocturnal complex bizarre visual hallucinations when treated with 18 mg Osmotic Release Oral System (OROS) methylphenidate (MPH)." | 7.77 | Long lasting complex nocturnal hallucinations during Osmotic Release Oral System (OROS) methylphenidate treatment in a 7-year old girl. ( Goetz, M; Hrdlicka, M; Prihodova, I, 2011) |
| " Withdrawal of the narcolepsy treatment and initiation of haloperidol 1 mg/day (the only antipsychotic treatment she could tolerate) improved the delusions, hallucinations and dysphoria but worsened the narcolepsy symptoms." | 3.85 | Narcolepsy-cataplexy and psychosis: a case study. ( Arango-Lopez, C; Canellas-Dols, F; Delgado, C; Peraita-Adrados, R, 2017) |
| "We report a case of a girl with Attention deficit hyperactivity disorder (ADHD) and Oppositional defiant disorder (ODD) who experienced a 3-hour episode of nocturnal complex bizarre visual hallucinations when treated with 18 mg Osmotic Release Oral System (OROS) methylphenidate (MPH)." | 3.77 | Long lasting complex nocturnal hallucinations during Osmotic Release Oral System (OROS) methylphenidate treatment in a 7-year old girl. ( Goetz, M; Hrdlicka, M; Prihodova, I, 2011) |
| "Carvone is a monoterpene that is present in spearmint (Mentha spicata) and caraway (Carum carvi) essential oils and has been shown to have anticonvulsant effects, likely through the blockade of voltage-gated sodium channels, and anxiolytic-like effects." | 1.43 | Antimanic-like effects of (R)-(-)-carvone and (S)-(+)-carvone in mice. ( Andreatini, R; Barcaro, IM; de Sousa, DP; Nogoceke, FP, 2016) |
| "Drug-induced sleep fragmentation can cause sleep disturbances either via their intended pharmacological action or as a side effect." | 1.37 | A hidden Markov model to assess drug-induced sleep fragmentation in the telemetered rat. ( Ackaert, O; Diack, C; Fairman, D; Gurrell, R; Ivarsson, M; Ploeger, BA; van der Graaf, PH, 2011) |
| "After sleep deprivation (13:00-19:00), compensatory excessive sleepiness (19:00-01:00) was observed in rats." | 1.36 | Studies on wakefulness-promoting effect of memantine in rats. ( Ishida, T; Kamei, C; Obara, Y, 2010) |
| "2." | 1.27 | Biological challenges in obsessive compulsive disorder. ( Joffe, RT; Swinson, RP, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canellas-Dols, F | 1 |
| Delgado, C | 1 |
| Arango-Lopez, C | 1 |
| Peraita-Adrados, R | 1 |
| Nogoceke, FP | 1 |
| Barcaro, IM | 1 |
| de Sousa, DP | 1 |
| Andreatini, R | 1 |
| Niijima-Yaoita, F | 1 |
| Nagasawa, Y | 1 |
| Tsuchiya, M | 1 |
| Arai, Y | 1 |
| Tadano, T | 1 |
| Tan-No, K | 1 |
| Ramsey, CS | 1 |
| Werchan, PM | 1 |
| Isdahl, WM | 1 |
| Fischer, J | 1 |
| Gibbons, JA | 1 |
| Ishida, T | 1 |
| Obara, Y | 1 |
| Kamei, C | 1 |
| Diack, C | 1 |
| Ackaert, O | 1 |
| Ploeger, BA | 1 |
| van der Graaf, PH | 1 |
| Gurrell, R | 1 |
| Ivarsson, M | 1 |
| Fairman, D | 1 |
| Goetz, M | 1 |
| Prihodova, I | 1 |
| Hrdlicka, M | 1 |
| Bray, CL | 1 |
| Cahill, KS | 1 |
| Oshier, JT | 1 |
| Peden, CS | 1 |
| Theriaque, DW | 1 |
| Flotte, TR | 1 |
| Stacpoole, PW | 1 |
| Boonstra, AM | 1 |
| Kooij, JJ | 1 |
| Oosterlaan, J | 1 |
| Sergeant, JA | 1 |
| Buitelaar, JK | 1 |
| Van Someren, EJ | 1 |
| Gruber, R | 1 |
| Grizenko, N | 1 |
| Schwartz, G | 1 |
| Bellingham, J | 1 |
| Guzman, R | 1 |
| Joober, R | 1 |
| Bishop, C | 1 |
| Roehrs, T | 1 |
| Rosenthal, L | 1 |
| Roth, T | 1 |
| Swinson, RP | 1 |
| Joffe, RT | 1 |
| Ananth, J | 1 |
| Ruskin, R | 1 |
4 trials available for methylphenidate and Inadequate Sleep
| Article | Year |
|---|---|
Methylphenidate does not improve cognitive function in healthy sleep-deprived young adults.
Topics: Adult; Central Nervous System Stimulants; Cognition; Female; Humans; Male; Methylphenidate; Placebos | 2004 |
Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Circadian R | 2007 |
Performance on the continuous performance test in children with ADHD is associated with sleep efficiency.
Topics: Arousal; Attention; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder | 2007 |
Alerting effects of methylphenidate under basal and sleep-deprived conditions.
Topics: Adult; Affect; Attention; Central Nervous System Stimulants; Female; Heart Rate; Humans; Male; Methy | 1997 |
9 other studies available for methylphenidate and Inadequate Sleep
| Article | Year |
|---|---|
Narcolepsy-cataplexy and psychosis: a case study.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compound | 2017 |
Antimanic-like effects of (R)-(-)-carvone and (S)-(+)-carvone in mice.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Cyclohexane Monoterpenes; Male; Methylphenidate; Mice; | 2016 |
Effects of methylphenidate on the impairment of spontaneous alternation behavior in mice intermittently deprived of REM sleep.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Hippocampus; Male; M | 2016 |
Acceleration tolerance at night with acute fatigue and stimulants.
Topics: Acceleration; Adaptation, Physiological; Adult; Aerospace Medicine; Amphetamine; Analysis of Varianc | 2008 |
Studies on wakefulness-promoting effect of memantine in rats.
Topics: Analysis of Variance; Animals; Benzazepines; Central Nervous System Stimulants; Dopamine Antagonists | 2010 |
A hidden Markov model to assess drug-induced sleep fragmentation in the telemetered rat.
Topics: Animals; Drug Evaluation, Preclinical; Drugs, Investigational; Electroencephalography; Electromyogra | 2011 |
Long lasting complex nocturnal hallucinations during Osmotic Release Oral System (OROS) methylphenidate treatment in a 7-year old girl.
Topics: Administration, Oral; Attention Deficit and Disruptive Behavior Disorders; Central Nervous System St | 2011 |
Biological challenges in obsessive compulsive disorder.
Topics: Adult; Affect; Behavior; Female; Humans; Male; Methylphenidate; Obsessive-Compulsive Disorder; Sleep | 1988 |
Treatment of intractable depression.
Topics: Amantadine; Antidepressive Agents; Depression; Dextroamphetamine; Drug Therapy, Combination; Hormone | 1974 |